Larson RA - Search Results

1

Histone deacetylase inhibitor romidepsin has differential activity in core binding factor acute myeloid leukemia.

Odenike OM, Alkan S, Sher D, Godwin JE, Huo D, Brandt SJ, Green M, Xie J, Zhang Y, Vesole DH, Stiff P, Wright J, Larson RA, Stock W. Odenike OM, et al. Among authors: larson ra. Clin Cancer Res. 2008 Nov 1;14(21):7095-101. doi: 10.1158/1078-0432.CCR-08-1007. Clin Cancer Res. 2008. PMID: 18981008 Free PMC article. Clinical Trial.

2

Low O6-alkylguanine DNA alkyltransferase activity in the peripheral blood lymphocytes of patients with therapy-related acute nonlymphocytic leukemia.

Sagher D, Karrison T, Schwartz JL, Larson R, Meier P, Strauss B. Sagher D, et al. Cancer Res. 1988 Jun 1;48(11):3084-9. Cancer Res. 1988. PMID: 2452685

3

Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia.

Zhang Y, Strissel P, Strick R, Chen J, Nucifora G, Le Beau MM, Larson RA, Rowley JD. Zhang Y, et al. Among authors: larson ra. Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3070-5. doi: 10.1073/pnas.042702899. Epub 2002 Feb 26. Proc Natl Acad Sci U S A. 2002. PMID: 11867721 Free PMC article.

4

Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420.

Farag SS, George SL, Lee EJ, Baer M, Dodge RK, Becknell B, Fehniger TA, Silverman LR, Crawford J, Bloomfield CD, Larson RA, Schiffer CA, Caligiuri MA. Farag SS, et al. Among authors: larson ra. Clin Cancer Res. 2002 Sep;8(9):2812-9. Clin Cancer Res. 2002. PMID: 12231521 Clinical Trial.

5

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

Smith SM, Le Beau MM, Huo D, Karrison T, Sobecks RM, Anastasi J, Vardiman JW, Rowley JD, Larson RA. Smith SM, et al. Among authors: larson ra. Blood. 2003 Jul 1;102(1):43-52. doi: 10.1182/blood-2002-11-3343. Epub 2003 Mar 6. Blood. 2003. PMID: 12623843 Free article.

6

Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: results from CALGB study 9013.

Silver RT, Peterson BL, Szatrowski TP, Powell BL, Stock W, Carroll AJ, Bloomfield CD, Schiffer CA, Larson RA. Silver RT, et al. Among authors: larson ra. Leuk Lymphoma. 2003 Jan;44(1):39-48. doi: 10.1080/1042819021000040260. Leuk Lymphoma. 2003. PMID: 12691141 Clinical Trial.

7

A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases.

Odenike OM, Sobecks RM, Janisch L, Huo D, Zimmerman TM, Daugherty CK, Ratain MJ, Larson RA. Odenike OM, et al. Among authors: larson ra. Cancer Chemother Pharmacol. 2004 Dec;54(6):553-61. doi: 10.1007/s00280-004-0857-3. Epub 2004 Sep 2. Cancer Chemother Pharmacol. 2004. PMID: 15349753 Clinical Trial.

8

Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignancies.

Zimmerman TM, Harlin H, Odenike OM, Berk S, Sprague E, Karrison T, Stock W, Larson RA, Ratain MJ, Gajewski TF. Zimmerman TM, et al. Among authors: larson ra. J Clin Oncol. 2004 Dec 1;22(23):4816-22. doi: 10.1200/JCO.2004.03.200. J Clin Oncol. 2004. PMID: 15570084 Clinical Trial.

9

Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity.

Marcucci G, Stock W, Dai G, Klisovic RB, Liu S, Klisovic MI, Blum W, Kefauver C, Sher DA, Green M, Moran M, Maharry K, Novick S, Bloomfield CD, Zwiebel JA, Larson RA, Grever MR, Chan KK, Byrd JC. Marcucci G, et al. Among authors: larson ra. J Clin Oncol. 2005 May 20;23(15):3404-11. doi: 10.1200/JCO.2005.09.118. Epub 2005 Apr 11. J Clin Oncol. 2005. PMID: 15824414 Clinical Trial.

10

Treatment of relapsed chronic lymphocytic leukemia by 72-hour continuous infusion or 1-hour bolus infusion of flavopiridol: results from Cancer and Leukemia Group B study 19805.

Byrd JC, Peterson BL, Gabrilove J, Odenike OM, Grever MR, Rai K, Larson RA; Cancer and Leukemia Group B. Byrd JC, et al. Among authors: larson ra. Clin Cancer Res. 2005 Jun 1;11(11):4176-81. doi: 10.1158/1078-0432.CCR-04-2276. Clin Cancer Res. 2005. PMID: 15930354 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

633 results

Search Page